Investment Thesis
Thermo Fisher demonstrates robust financial health with strong profitability metrics, healthy cash generation, and solid leverage ratios. Despite modest revenue growth of 3.9% YoY and flat net income growth, the company maintains excellent operational efficiency with 17.4% operating margins and generates substantial free cash flow of $6.3B annually.
TMO Strengths
- Exceptional operating margin of 17.4% demonstrates pricing power and operational efficiency
- Strong free cash flow generation of $6.3B with 14.1% FCF margin supports dividends and debt service
- Solid liquidity position with 1.89x current ratio and 1.53x quick ratio provides financial flexibility
- Conservative leverage at 0.73x debt-to-equity with strong 21.3x interest coverage indicates low financial risk
- Consistent profitability with 15.0% net margin and 12.6% ROE showing effective capital deployment
TMO Risks
- Sluggish organic revenue growth of only 3.9% YoY suggests limited organic expansion momentum
- Net income essentially flat YoY (-0.3%) despite revenue growth indicates margin pressure or one-time charges
- High long-term debt of $39.2B relative to net income creates vulnerability to interest rate increases
- Modest ROA of 6.1% relative to $110.3B asset base suggests underutilized asset base or acquisition-driven growth
- Gross margin compression to 6.8% is concerningly low and warrants investigation into cost structure
Key Metrics to Watch
- Organic revenue growth rate and segment performance breakdown
- Gross margin trend and cost of goods sold trajectory
- Free cash flow sustainability and working capital management
- Debt reduction pace and leverage ratio progression
- Operating margin maintenance amid pricing and cost dynamics
TMO Financial Metrics
Revenue
$44.6B
Net Income
$6.7B
EPS (Diluted)
$17.74
Free Cash Flow
$6.3B
Total Assets
$110.3B
Cash Position
$9.9B
TMO Profitability Ratios
Gross Margin
6.8%
Operating Margin
17.4%
Net Margin
15.0%
ROE
12.6%
ROA
6.1%
FCF Margin
14.1%
TMO Balance Sheet & Liquidity
Current Ratio
1.89x
Quick Ratio
1.53x
Debt/Equity
0.73x
Debt/Assets
0.0%
Interest Coverage
21.34x
Long-term Debt
$39.2B
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: Mar 18, 2026 |
Data as of: 2025-12-31 |
Powered by Claude AI